These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29314079)

  • 1. High frequency of MGUS in DSP.
    Abraham A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    Muscle Nerve; 2018 Jun; 57(6):1018-1021. PubMed ID: 29314079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polyneuropathy associated with monoclonal gammopathy of undetermined significance].
    Moth Henriksen M; Kolmos EB; Abildgaard N; Schrøder HD; Sindrup S
    Ugeskr Laeger; 2012 Oct; 174(43):2630-4. PubMed ID: 23095652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
    Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyneuropathy and monoclonal gammopathy of undetermined significance (MGUS); update of a clinical experience.
    Matà S; Torricelli S; Barilaro A; Grippo A; Forleo P; Del Mastio M; Sorbi S
    J Neurol Sci; 2021 Apr; 423():117335. PubMed ID: 33647732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathy.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2017 Aug; 379():94-98. PubMed ID: 28716288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
    Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
    Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional causes for distal sensory polyneuropathy in diabetic patients.
    Gorson KC; Ropper AH
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):354-8. PubMed ID: 16484643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
    Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
    Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S; Kyle RA; Dyck PJ
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.
    Wolf HH; Posa A; Panitz S; Kornhuber M; Hanisch F
    Acta Neurol Scand; 2015 Sep; 132(3):212-5. PubMed ID: 25644365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy.
    Eurelings M; Notermans NC; Van de Donk NW; Lokhorst HM
    Muscle Nerve; 2001 Oct; 24(10):1295-302. PubMed ID: 11562908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
    Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in patients with polyneuropathy associated with different types of monoclonal gammopathy of undetermined significance.
    Opalic M; Peric S; Palibrk A; Bozovic I; Bjelica B; Stevic Z; Basta I
    Acta Neurol Belg; 2020 Oct; 120(5):1133-1138. PubMed ID: 31201672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Italian multicentre study on the prevalence of distal symmetric polyneuropathy: correlation between clinical variables and nerve conduction parameters. Italian Diabetic Neuropathy Committee.
    Comi G; Fedele D; Coscelli C; Cucinotta D; Feldman EL; Ghirlanda G; Negrin P; Santeusanio F; Maderna L
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():546-52. PubMed ID: 10689507
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M; Tomonaga M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
    Fisher MA; Wilson JR
    Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS; Gundrum JD; Neuner JM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.